<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0232841.ref016">
 <label>16</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Thindwa</surname>
   <given-names>D.</given-names>
  </name>, 
  <name>
   <surname>MacPherson</surname>
   <given-names>P.</given-names>
  </name>, 
  <name>
   <surname>Choko</surname>
   <given-names>A. T.</given-names>
  </name>, 
  <name>
   <surname>Khundi</surname>
   <given-names>M.</given-names>
  </name>, 
  <name>
   <surname>Sambakunsi</surname>
   <given-names>R.</given-names>
  </name>, 
  <name>
   <surname>Ngwira</surname>
   <given-names>L. G.</given-names>
  </name>, 
  <etal>et al</etal>
  <year>2018</year> “
  <article-title>Completion of Isoniazid Preventive Therapy among Human Immunodeficiency Virus Positive Adults in Urban Malawi</article-title>.” 
  <source>
   <italic toggle="yes">The International Journal of Tuberculosis and Lung Disease</italic>: 
   <italic toggle="yes">The Official Journal of the International Union against Tuberculosis and Lung Disease</italic>
  </source>
  <volume>22</volume> (
  <issue>3</issue>): 
  <fpage>273</fpage>–
  <lpage>79</lpage>.
 </mixed-citation>
</ref>
